A CMOS Chip NMR: The Next Generation of Molecular Phenotyping for Health and Disease
Weng Kung PENG
International Iberian Nanotechnology Laboratory
Weng Kung is a Research Group Leader at International Iberian Nanotechnology Laboratory. His group interest focuses on developing and translating microscale nuclear magnetic resonance for the next generation of molecular phenotyping in precision medicine. Prior to joining INL, he was Research Scientist at SMART-MIT. Weng Kung is the recipient of several internationally competitive awards such as Japan Ministry of Science and Technology Scholar, MIT Postdoctoral Fellowship, MIT Technology Ignition, and the China Top 1000 Youth Talents. In 2014, Weng Kung was listed as one of the “100 Leading Global Thinkers” by Foreign Policy in recognition of his team disruptive technology.
Abstract
In the early 90’s, as the first human genome project was initiated, an extensive effort has been placed on mapping the role of genes in the onset of disease. Genetic contribution to different diseases however, were found to... [ view full abstract ]
In the early 90’s, as the first human genome project was initiated, an extensive effort has been placed on mapping the role of genes in the onset of disease. Genetic contribution to different diseases however, were found to be varies and often very little, with non-genetic factors (e.g., environmental hazards, diet, microbiome) having much greater attributable risks, and thereby producing ‘stochastically’ large phenotypic pool. The key goals to understanding human health and disease depend on the success of translating technological innovations (e.g., molecular diagnostic, molecular imaging) into medical research (and eventually into clinical settings), and the ability to access the ‘genotype-phenotype’ correlogram through various omics-platform (e.g., proteomic, metabolomics, phenomics).
Our research focuses addressing the challenges (and unprecedented opportunities) by introducing a new generation of molecular phenotyping by rapidly mapping out the water-protein interactions (thus providing an 'inverse proteomic' information) within the microenvironment of biological fluids (e.g., blood, serum). We demonstrated that highly unique and specific `molecular fingerprinting´ for disease diagnosis using a single drop of blood (<1µL) obtained in less than 10 minutes using our home-built portable NMR spectrometer. Some of our successful translational clinical works (and in the pipeline) includes the rapid and label-free malaria screening, rapid molecular phenotyping of oxidative stress in diabetes mellitus, and sub-stratification of endometriosis and molecular phenotyping in hemoglobinopathies.
- W.K. Peng, et.al., Micromagnetic resonance relaxometry for rapid label-free malaria diagnosis, Nature Medicine 20, 1069-1073 (2014)
- W.K. Peng, Chen, L. & J. Han, Development of miniaturized, portable magnetic resonance relaxometry system for point-of-care medical diagnosis, Review of Scientific Instruments 83, 095115 (2012)
- W.K. Peng, D. Lim, T.T. Ng & T.P. Loh, Two-dimensional T1-T2 Correlational Spectroscopy for Rapid and Label-free Molecular Phenotyping in Hemoglobinopathies, (Under-Reviewed, 2018).
Authors
-
Weng Kung PENG
(International Iberian Nanotechnology Laboratory)
Topic Areas
Biomarkers and diagnostics, liquid biopsy, imaging, biochip/microarray technologies, advan , Emerging opportunities in personalized medicine, cutting-edge new strategies and solutions
Session
OS3b-A » Multi-Topics (16:00 - Wednesday, 27th June, Amphitheater)
Presentation Files
The presenter has not uploaded any presentation files.